| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/27/2007 | US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases |
| 03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 03/27/2007 | US7196097 MAP kinase inhibitors; treating arthritis, ankylosing spondylitis, psoriatic arthritis, various gastrointestinal disorders; adult respiratory distress syndrome, asthma, COPD and Alzheimer's disease. |
| 03/27/2007 | US7196096 Substituted amines of spirofuropyridines useful in therapy |
| 03/27/2007 | US7196095 anti-protoazoal; poultry feed; therapy for cytokine mediated disease i.e. osteoarthritis, cerebral malaria, chronic pulmonary inflammatory disease, silicosis, pulmonary sarcosis, bone resorption diseases, reperfusion injury, graft v. host rejection |
| 03/27/2007 | US7196094 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 03/27/2007 | US7196076 Androgen receptor modulators and methods of use thereof |
| 03/27/2007 | CA2326611C Substituted heterocyclic derivatives |
| 03/22/2007 | WO2007033232A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
| 03/22/2007 | WO2007033137A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
| 03/22/2007 | WO2007032936A2 Azafused cyclin dependent kinase inhibitors |
| 03/22/2007 | WO2007032699A1 (+)-and-(-)-trans-2,3,4,4a,5,9b-hexahydro-2,8-dimethyl-1h-pyrido[4,3-b] indole optical isomers |
| 03/22/2007 | WO2007032466A1 Heterocyclic compound, and production process and use thereof |
| 03/22/2007 | WO2007032357A1 Compound having oxadiazole ring structure bonded with aromatic heterocyclic ring and organic electroluminescent device |
| 03/22/2007 | WO2007031977A2 Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors |
| 03/22/2007 | WO2007031838A1 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
| 03/22/2007 | WO2007031747A1 Imdolizine derivatives as ligands of the crth2 receptor |
| 03/22/2007 | WO2007031739A1 Heterobicyclic compounds as glucokinase activators |
| 03/22/2007 | WO2007031558A1 5-amino-4-hydroxy-7- (imidazo [1,2-a] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
| 03/22/2007 | WO2007031529A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
| 03/22/2007 | WO2007030934A2 Methods of modulating neurotrophin-mediated activity |
| 03/22/2007 | WO2007016353A3 Substituted tetrahydro-1h-pyrido[4,3,b]indoles as serotonin receptor agonists and antagonists |
| 03/22/2007 | WO2006129237A3 Novel piperidine carboxylic acid amide derivatives |
| 03/22/2007 | WO2006129120A9 Benzotriazepinone derivatives |
| 03/22/2007 | WO2004046144A8 8-substituted imidazopyridines |
| 03/22/2007 | US20070066664 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses, materials for their synthesis |
| 03/22/2007 | US20070066645 Novel compounds |
| 03/22/2007 | US20070066644 1-[[1-[(2-Amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-b]pyridin-3-yl]piperidine |
| 03/22/2007 | US20070066642 Novel imidazopyridine compound ii with therapeutic effect |
| 03/22/2007 | US20070066640 Heteroaryl-substituted pyrrolo'2,3-b1 pyridine derivatives as crf receptor antagonists |
| 03/22/2007 | US20070066639 Oxime substituted imidazoquinolines |
| 03/22/2007 | US20070066621 Novel 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridines, pyrazolo[1,5-c]pyrimidines and 2h-indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1,2-a]pyridines, and imidazo[1,5-a]pyrazines as cyclin dependent kinase inhibitors |
| 03/22/2007 | US20070066619 Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 03/22/2007 | US20070066618 Use of EP4 Receptor Ligands in the Treatment of IL-6 Involved Diseases |
| 03/22/2007 | US20070066605 Fungicides |
| 03/22/2007 | US20070066600 Compounds |
| 03/22/2007 | US20070066599 New compounds |
| 03/22/2007 | US20070066598 Compounds |
| 03/22/2007 | US20070066592 5-{6-[(3R)-1-azabicyclo[2.2.2]oct-3-yloxy]pyridazin-3-yl}-1H-indole; attention deficit disorder, attention deficit hyperactivity disorder, Alzheimer's disease, senile dementia, AIDS dementia, Pick's Disease, dementia associated with Down's syndrome; alpha 7 nAChR ligands modulators |
| 03/22/2007 | US20070066586 Aniline derivatives |
| 03/22/2007 | CA2622725A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
| 03/22/2007 | CA2622614A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
| 03/22/2007 | CA2622605A1 Heterocycle compound, and production process and application thereof |
| 03/22/2007 | CA2622574A1 Methods of modulating neurotrophin-mediated activity |
| 03/22/2007 | CA2622372A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
| 03/22/2007 | CA2622082A1 5-amino-4-hydroxy-7- (imidazo [1,2-a] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
| 03/22/2007 | CA2621983A1 Azafused cyclin dependent kinase inhibitors |
| 03/22/2007 | CA2617394A1 2-aniline-4-aryl substituted thiazole derivatives |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1763529A1 A process for the preparation of risperidone |
| 03/21/2007 | EP1763528A1 Pyrazolopyridine derivatives |
| 03/21/2007 | EP1763524A1 Indole derivatives and use thereof as kinase inhibitors |
| 03/21/2007 | EP1539752B1 Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via novel imidazo[4,5-c]quinolin-4-cyano and 1h-imidazo[4,5-c]quinolin-4-carboxamide intermediates |
| 03/21/2007 | EP1487821B1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases |
| 03/21/2007 | EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 03/21/2007 | CN1934113A Compositions useful as inhibitors of protein kinases |
| 03/21/2007 | CN1934111A Heteroaryl-fused pyrazolo derivatives |
| 03/21/2007 | CN1934100A Substituted quinazoline or pyridopyrimidine derivative |
| 03/21/2007 | CN1934094A Diaryl-substituted five-membered heterocycle derivative |
| 03/21/2007 | CN1934091A Imidazole compounds for the treatment of neurodegenerative disorders |
| 03/21/2007 | CN1933839A Compounds and methods of use |
| 03/21/2007 | CN1931859A New fused imidazole derivative |
| 03/21/2007 | CN1305873C [18F] Fluorin marked pyridine compound and method for preparing the same and uses as dopamine D4 receptor developer |
| 03/21/2007 | CN1305872C Process for producing quinazoline ditosylate salt compounds |
| 03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/21/2007 | CN1305848C 2,3-dihydro-isoindol-1-ones with MAO-B inhibiting activity |
| 03/21/2007 | CN1305475C Boronic ester and acid compounds, synthesis and uses |
| 03/20/2007 | US7192969 Ester derivatives |
| 03/20/2007 | US7192968 Ethylenediamine derivatives |
| 03/20/2007 | US7192967 Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 03/20/2007 | US7192964 4-oxoimidazolidine-2-spiropiperidine derivatives |
| 03/20/2007 | CA2443307C Quinolone- and naphthyridone-carboxylic acid derivatives |
| 03/20/2007 | CA2162154C Use of a transition metal complex for the treatment of septic shock |
| 03/15/2007 | WO2007030061A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 03/15/2007 | WO2007029847A1 Bicyclic aromatic substituted pyridone derivative |
| 03/15/2007 | WO2007029629A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity |
| 03/15/2007 | WO2007029156A2 Isoindoledione derivatives as adrenergic receptor antagonists |
| 03/15/2007 | WO2007029078A2 Succinimide and glutarimide derivatives as adrenergic receptor antagonists |
| 03/15/2007 | WO2007029037A2 Class iia histone deacetylase (hdac) substrate |
| 03/15/2007 | WO2007029035A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | WO2007028734A1 Dihydroquinophenanthrine dione and tetrahydroquinophenanthrine dione fluorescent whitening agents |
| 03/15/2007 | WO2007028638A1 Fused and spirocycle compounds and the use thereof |
| 03/15/2007 | WO2007028460A1 TETRAHYDRO-β-CARBOLIN-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS |
| 03/15/2007 | WO2006138714A3 Naphthyridine compounds |
| 03/15/2007 | WO2006131884A3 Thiazole substituted diazabicyclononane or-nonene derivatives as renin inhibitors |
| 03/15/2007 | WO2006128692A3 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system |
| 03/15/2007 | WO2006036926B1 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 03/15/2007 | WO2005063745A8 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
| 03/15/2007 | US20070060755 Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates |
| 03/15/2007 | US20070060754 Alkoxy substituted imidazoquinolines |
| 03/15/2007 | US20070060629 Large conductance calcium-activated k channel opener |
| 03/15/2007 | US20070060601 Mitotic kinesin inhibitors |
| 03/15/2007 | US20070060588 Fused bicycloheterocycle substituted quinuclidine derivatives |
| 03/15/2007 | US20070060581 1-Sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 03/15/2007 | US20070060578 5-Oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
| 03/15/2007 | US20070060577 5-Oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
| 03/15/2007 | US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction |
| 03/15/2007 | US20070060566 Benzazepine derivatives as histamine h3 antagonists |
| 03/15/2007 | US20070060563 Quinuclidine derivatives binding to mucarinic m3 receptors |
| 03/15/2007 | CA2622079A1 Amide and carbamate derivatives of alkyl substituted n-[4-(4-amino-1h-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamides and methods |